Deactivation of cyclophosphamide (NSC-26271) metabolites by sulfhydryl compounds
- PMID: 1277211
Deactivation of cyclophosphamide (NSC-26271) metabolites by sulfhydryl compounds
Abstract
The reaction of 4-hydroxycyclophosphamide (4-hydroxy-CP) with sulfhydryl (SH) compounds was studied, and although the cytotoxic activity was lost a significant stabilization of the alkylating capacity was observed at the same time. We were able to show that the reaction of 4-hydroxy-CP with thiols lead to an equilibrium between the reaction product and the starting substrates. On the basis of this equilibrium the increased stabilization of the alkylating capacity of the 4-hydroxy-CP derivatives by raising the SH concentration can be explained. The different degrees of stabilization depending on the structure of the thiol results from different equilibria. the effect on the toxification reaction resulting from this equilibrium, in connection with the tautomeric equilibrium between 4-hydroxy-CP and aldophosphamide, is discussed.
Similar articles
-
The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity.Cancer Treat Rep. 1976 Apr;60(4):309-15. Cancer Treat Rep. 1976. PMID: 1277206
-
Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.Cancer Treat Rep. 1976 Apr;60(4):337-46. Cancer Treat Rep. 1976. PMID: 1277209
-
Studies on the in vivo formation of acrolein: 3-hydroxy-propylmercapturic acid as an index of cyclophosphamide (NSC-26271) activation.Cancer Treat Rep. 1976 Apr;60(4):327-35. Cancer Treat Rep. 1976. PMID: 1277208
-
The chemistry of the metabolites of cyclophosphamide.Curr Pharm Des. 1999 Aug;5(8):627-43. Curr Pharm Des. 1999. PMID: 10469895 Review.
-
The comparative pharmacology of cyclophosphamide and ifosfamide.Semin Oncol. 1982 Dec;9(4 Suppl 1):2-7. Semin Oncol. 1982. PMID: 6761865 Review. No abstract available.
Cited by
-
Chemical characterization of ASTA Z 7557 (INN mafosfamide, CIS-4-sulfoethylthio-cyclophosphamide), a stable derivative of 4-hydroxy-cyclophosphamide.Invest New Drugs. 1984;2(2):133-9. doi: 10.1007/BF00232342. Invest New Drugs. 1984. PMID: 6469506
-
Comparison of in vitro activity of epipodophyllotoxins with other chemotherapeutic agents in human medulloblastomas.Br J Cancer. 1991 Dec;64(6):1051-9. doi: 10.1038/bjc.1991.464. Br J Cancer. 1991. PMID: 1662532 Free PMC article.
-
Interaction of alpha-interferon with chemotherapeutic agents: effects on cytotoxic drug metabolism and multiple drug resistance.Med Oncol. 1995 Mar;12(1):9-14. doi: 10.1007/BF01571403. Med Oncol. 1995. PMID: 8542251 Review. No abstract available.
-
Enzymatic toxicogenation of "activated" cyclophosphamide by 3'-5' exonucleases.J Cancer Res Clin Oncol. 1983;105(1):27-9. doi: 10.1007/BF00391828. J Cancer Res Clin Oncol. 1983. PMID: 6300134 Free PMC article.
-
[On the binding of cyclophosphamide and cyclophosphamide-metabolites to serum-albumin (author's transl)].Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1978 May 31;91(2):127-42. doi: 10.1007/BF00284020. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1978. PMID: 27021 German. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous